Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiankun Hu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Medicine|June 6, 2020
Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver diseaseQiang Li, Chenlu Huang, Wei Xu, et al.
Medicine|July 16, 2019
A simple algorithm for non-invasive diagnosis of significant liver histological changes in patients with CHB and normal or mildly elevated alanine transaminase levelsQiang Li, Chenlu Huang, Wei Xu, et al.
Infectious Diseases and Therapy|December 15, 2022
Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort StudyWei Xu, Qiankun Hu, Chong Chen, et al.
Scientific Reports|February 19, 2020
Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infectionQiang Li, Chong Chen, Chenlu Huang, et al.
Infection and Drug Resistance|April 6, 2023
FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort StudyWei Xu, Qiankun Hu, Chong Chen, et al.
Discovery Medicine|October 1, 2020
Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infectionChenlu Huang, Qiang Li, Wei Xu, et al.
Journal of Viral Hepatitis|December 18, 2022
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfaXiongyue Cao, Qiankun Hu, Wei Xu, et al.
Hepatology International|September 29, 2020
Efficacy of peg-interferon-nucleoside analog sequential optimization therapy in HBeAg-positive patients with CHBWei Xu, Qiang Li, Chenlu Huang, et al.
Frontiers in Immunology|March 6, 2026
Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failureXiaoqin Liu, Xuhua Jiang, Xueyun Zhang, et al.
International Journal of Molecular Sciences|January 25, 2025
The MADS-Box Transcription Factor EjAGL18 Negatively Regulates Malic Acid Content in Loquat by Repressing <i>EjtDT1</i>Zhuoheng Chi, Luwei Wang, Qiankun Hu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Medicine|June 6, 2020
Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver diseaseQiang Li, Chenlu Huang, Wei Xu, et al.
Medicine|July 16, 2019
A simple algorithm for non-invasive diagnosis of significant liver histological changes in patients with CHB and normal or mildly elevated alanine transaminase levelsQiang Li, Chenlu Huang, Wei Xu, et al.
Infectious Diseases and Therapy|December 15, 2022
Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort StudyWei Xu, Qiankun Hu, Chong Chen, et al.
Scientific Reports|February 19, 2020
Noninvasive models for predicting poor prognosis of chronic HBV infection patients precipitating acute HEV infectionQiang Li, Chong Chen, Chenlu Huang, et al.
Infection and Drug Resistance|April 6, 2023
FibroScan Predicts Liver Fibrosis Progression in Chronic HBV Infection Patients with No Clear Indication for Antiviral Therapy: A Retrospective Cohort StudyWei Xu, Qiankun Hu, Chong Chen, et al.
Discovery Medicine|October 1, 2020
Serum HBV RNA levels predict significant liver fibrosis in patients with chronic HBV infectionChenlu Huang, Qiang Li, Wei Xu, et al.
Journal of Viral Hepatitis|December 18, 2022
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon-alfaXiongyue Cao, Qiankun Hu, Wei Xu, et al.
Hepatology International|September 29, 2020
Efficacy of peg-interferon-nucleoside analog sequential optimization therapy in HBeAg-positive patients with CHBWei Xu, Qiang Li, Chenlu Huang, et al.
Frontiers in Immunology|March 6, 2026
Methyl-CpG-binding domain protein 2 epigenetically represses monocyte HLA-DR expression and promotes immune paralysis in HBV-related acute-on-chronic liver failureXiaoqin Liu, Xuhua Jiang, Xueyun Zhang, et al.
International Journal of Molecular Sciences|January 25, 2025
The MADS-Box Transcription Factor EjAGL18 Negatively Regulates Malic Acid Content in Loquat by Repressing <i>EjtDT1</i>Zhuoheng Chi, Luwei Wang, Qiankun Hu, et al.
Pageof 3